PHARMACEUTICAL COMPOSITION CONTAINING THROMBOLYTIC PEPTIDE-TETRAHYDROISOQUINOLINE CONJUGATE Russian patent published in 2024 - IPC A61K31/4725 A61K38/06 A61K47/26 A61K47/55 A61K9/19 

Abstract RU 2825937 C1

FIELD: medicine; pharmaceutics.

SUBSTANCE: object 1 is a pharmaceutical composition containing (a) a compound of formula , or a pharmaceutically acceptable salt thereof, and (b) a pharmaceutically acceptable excipient, where the pharmaceutically acceptable excipient is mannitol, sorbitol, sucrose, lactose or trehalose, where the composition has a pH value equal to approximately pH 2 - pH 5.5 and the weight ratio of the compound and the pharmaceutically acceptable excipient is approximately from 1:1 to 1:9. Object 2 is lyophilized pharmaceutical composition containing (a) said compound or its pharmaceutically acceptable salt and (b) mannitol, wherein the weight ratio of the compound to mannitol is from about 1:1.3 to 1:3.8, and the pH of the pharmaceutical composition has a value of about 4.5 after reconstitution with normal saline to concentration of 10 to 20 mg/ml.

EFFECT: stability of the pharmaceutical composition.

14 cl, 1 dwg, 12 tbl, 6 ex

Similar patents RU2825937C1

Title Year Author Number
FORMULATIONS WITH ADENO-ASSOCIATED VIRUS 2017
  • Fiedler, Christian
  • Fritscher, Eva
  • Hasslacher, Meinhard
  • Mittergradnegger, Dominik
  • Tabish, Tanvir
RU2769196C2
METHOD OF PRODUCING BORTEZOMIB LYOPHILIZATE AND A PHARMACEUTICAL COMPOSITION CONTAINING BORTEZOMIB IN FORM OF A STABLE LYOPHILIZED PRODUCT OBTAINED BY SAID METHOD 2018
  • Nazarenko Anna Borisovna
  • Zakoriukin Nikolai Valentinovich
  • Kinasov Dmitrii Gurgenovich
RU2696854C1
BORTEZOMIB LYOPHILIZATE PRODUCTION METHOD AND THE BORTEZOMIB CONTAINING PHARMACEUTICAL COMPOSITION IN THE FORM OF STABLE LYOPHILIZATED PRODUCT PRODUCED BY SAID METHOD 2017
  • Nazarenko Anna Borisovna
  • Kinasov Dmitrij Gurgenovich
  • Ladygin Vyacheslav Vladimirovich
  • Kornev Kirill Olegovich
  • Zakoryukin Nikolaj Valentinovich
RU2659160C1
COMPOSITION CONTAINING HIGHLY CONCENTRATED ALPHA-1-PROTEINASE INHIBITOR AND METHOD OF ITS PREPARATION 2019
  • Rebbeor James
  • Miller Charles
  • Klos Anthony
  • Allgaier Eric
  • Zimmerman Thomas P
  • Wee Kevin
  • Stpeter Michelle
  • Glancy Kelly
RU2813136C1
PHARMACEUTICAL COMPOSITION CONTAINING BIOPHARMACEUTICAL DRUG 2011
  • Danek-Bullius Marina
  • Dojtel Britta
  • Fyurtinger Sabina
  • Pragl Berndt
  • Kutsman Drago
RU2587056C2
LIPOPEPTIDE COMPOSITION AND RELATED METHODS 2010
  • San Sofi
  • Naik Gaauri
  • O'Konnor Sandra
RU2607526C2
PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH-PURITY CANGRELOR, AND METHODS FOR PRODUCTION AND USE THEREOF 2015
  • Dutta Panna
  • Ding Min
  • Motheram Rajeshwar
  • Rafai Far Adel
RU2733409C2
PHARMACEUTICAL COMPOSITION CONTAINING PLASMINOGEN, AND USE THEREOF 2015
  • Blackman Davida
  • Plum Stacy
  • Garzon-Rodriguez, William
  • Yu Betty
  • Robitaille Martin
RU2711989C2
DOSAGE FORMS, SALTS AND POLYMORPHS OF TRANSNORSERTRALINE AND USING THEM 2010
  • Laflin Sharon M.
  • Sizenski Majkl Dzh.
  • Singkh Surendra P.
  • Uilkinson Skott Kh.
  • Khuang Chaj Gu
  • Bonejsija Filip Dzhejms
  • D'Sauza Sjuzan S.
RU2578956C2
ANESTHETIC COMPOSITION AND METHOD OF EYE ANESTHETIZATION 2020
  • Uram, Martin
RU2812900C2

RU 2 825 937 C1

Authors

Chou, Devid Chi-Kuang

Dates

2024-09-02Published

2020-09-24Filed